Générique et obsessions ou obsession du générique. A propos d'un cas de rechute d'un trouble obsessionnel compulsif lors d'une substitution de la fluoxétine par un générique

Medecine et Hygiene

Volumn 56, Issue 2229, 1998, Pages 2085-2087

  Hovaguimian, Th ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

FLUOCIM; FLUOXETINE; GENERIC DRUG; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DRUG CHOICE; DRUG EFFICACY; HUMAN; MALE; OBSESSION; RECURRENT DISEASE;

EID: 0032483709     PISSN: 00256749     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Abel J. Exposure with response prevention and serotoninergic antidepressants in the treatment of obsessive-compulsive disorder : A review and implication for interdisciplinary treatment. Behavior Research Therapy 1993; 31 : 463-78.
2. Salkowsky M, Krik J. Obsessional disorder. In : Cognitive behavioral therapy for psychiatric problems,? K. Hawton et al Ed.) 1989 ; 129-68.
3. Byerly MJ, et al. High doses of sertraline for treatment-resistant obsessive compulsive disorder; Am Psych 1996; 153: 1232-3.
4. Marks IM. Review of behvioral psychotherapy in obsessive-compulsive di- sorders. Am J Psych 1981; 138: 584-92.
5. Pato MT, Zohar-Kadouch R, Zohar J, et al. return of symptoms after discontinuation of clomipramine in patients with obsessive-compulsive disorder. Am J Psych 1988; 145: 1521-5.
6. Fontaine R, Chouinard G. Fluoxetine in the long-term maintenance treatment of obsessive compulsive disorder, Psychiatr Ann 1989; 19: 88-91.
7. Baer L. RicciardiaJ, Keuthen N, et al. Discontinuing obsessive-compulsive disordre medication with behavior therapy AM J Psych 1994; 151: 1842.
8. Wirth DD, Olsen BA, Hallenbeck DK, et al. Screening methods for impurities in multi-sourced fluoxetine hydrochloride drug substances and formulations. Chromatographia 1997; 46: 22.
9. Wirth D, Baertshi SW, Johnson RA, et al. Maillard reaction lactose and fluoxetine hydrochloride, a secondary amine. J Pharmacol Sc 1998; 87: 31-9.
10. Perry FM, Wirth DD, Olsen BA. Drug substitution and assumptions of equivalence. The Austr J Pharmacy 1997; 78: 106.
11. Lalvée M, «le nowel Obsessionnel», No 10, anil-juin, 1995.
12. Greist JH, Jefferson JW, Koback KA, et al. Efficacy and tolerability of serotonine transport inhibitors in obsessive-compulsive disorder. Arch Gene Psych 1995 ; 52 : 53-5.
13. Rasmussen, et al. A two year study of sertraline in the treatment of obsessivecompulsive disorder. Int Clin Psychopharmacol 1997 : 6 ; 309-16.
14. Preskom SH. Clinical pharmacology of selective serotonine reuptake inhibitors. Professional Communications Inc. 1996; 119.
15. Lamagnère F. Manies peurs et idées fixes, Edition Retz, Paris, 1994; 89-90.
16. Stein DJ, Spadaccin E, Hollander E. Meta-analysis of pharmacotherapy trials for obsessive-compulsive discorder, Intern Clin Pharmacol 1995; 10: 11-8.
17. Piccinelli M, Pini S, Bellantuono C, Wikinson G. Efficacy of drug treatment in Obsessive-compulsive Disorder - A meta-analysi review. Brit J Psych 1995; 166: 424-43.
18. Banahan BF, Kolassa EM, A Physician survey on generic drug and substitution of critical dose medications. Arch Intern Med 1997; 157: 2080-8.